TNFSF10 and type 1 diabetes mellitus: In addition to that, TRAIL can induce the elevation of tissue inhibitor of metalloproteinase-1 (TIMP-1) [73], whose increase might protect against T1DM by reducing MMP-9 pancreatic activity [73], which cleaves insulin and is generally higher in diabetic patients [74–76].